Immuron logo

Immuron

IMRN | NASDAQ
Chart Builder DCF Calculator
$0.90
+$0.02 (+2.82%)
At close: Nov 16, 2026, 4:00 PM ET
$0.92
+$0.02 (+1.72%)
After-hours: Nov 16, 2026, 7:00 PM ET
+2.82%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
39.5
+7.0 pts
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #542/1021 (Top 53%)

Key Statistics

Market Data

Market Cap $7.32M
1D Range
0.82 0.91
52W Range
0.70 1.84

Valuation (TTM)

PE -2.60
PB 0.96
EV/EBITDA -0.33

Valuation (NTM)

Forward PE N/A
Forward PEG 0.16
Price Target $0.00
Loading financial charts...

Profile

Immuron Limited is a biopharmaceutical company focused on the discovery, development, and global commercialization of polyclonal antibodies, with operations spanning Australia, the United States, and ...

Sector Healthcare
Industry Biotechnology
Employees 7
IPO Date Jun 9, 2017
Fiscal Year July - June

Latest News

No news articles available yet.

Earnings

Next Earnings
Feb 19, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.